Solana Co 8-K

What Happened Solana Company (formerly Helius Medical Technologies, Inc.) filed a Form 8-K (Item 8.01) dated February 20, 2026, reporting its current issued and outstanding equity. The company confirmed that 52,802,604 shares of common stock are issued and outstanding and that pre-funded warrants to purchase 23,930,181 shares are issued and outstanding. The filing is signed by Jeffrey S. Mathiesen, Chief Financial Officer, Treasurer and Secretary.

Key Details

• Filing date: February 20, 2026 (Form 8-K, Item 8.01).
• Common shares issued and outstanding: 52,802,604.
• Pre-funded warrants issued and outstanding: 23,930,181.
• Report signed by Jeffrey S. Mathiesen (CFO, Treasurer and Secretary).

Why It Matters The counts provided set the company’s current share base and the potential additional shares that could be created if the pre-funded warrants are exercised. Share and warrant totals are fundamental inputs for calculating market capitalization, basic and diluted shares outstanding, and potential dilution — all important for investors evaluating ownership percentages, per-share metrics, and valuation. Investors should watch subsequent filings for any exercises, conversions, or new issuances that would change these figures.